Provectus Biopharmaceuticals Inc (PVCT)
0.1948
0.00 (0.00%)
USD |
OTCM |
Apr 22, 16:00
Provectus Biopharmaceuticals Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| March 30, 2017 | 3.901 |
| March 29, 2017 | 4.942 |
| March 28, 2017 | 5.131 |
| March 27, 2017 | 5.352 |
| March 24, 2017 | 6.046 |
| March 23, 2017 | 4.010 |
| March 22, 2017 | 3.996 |
| March 21, 2017 | 4.195 |
| March 20, 2017 | 3.628 |
| March 17, 2017 | 3.144 |
| March 16, 2017 | 2.944 |
| March 15, 2017 | 2.939 |
| March 14, 2017 | 3.144 |
| March 13, 2017 | 2.997 |
| March 10, 2017 | 3.049 |
| March 09, 2017 | 3.049 |
| March 08, 2017 | 3.049 |
| March 07, 2017 | 2.807 |
| March 06, 2017 | 2.976 |
| March 03, 2017 | 2.839 |
| March 02, 2017 | 2.471 |
| March 01, 2017 | 2.904 |
| February 28, 2017 | 4.175 |
| February 27, 2017 | 3.154 |
| February 24, 2017 | 2.629 |
| Date | Value |
|---|---|
| February 23, 2017 | 2.713 |
| February 22, 2017 | 1.998 |
| February 21, 2017 | 1.966 |
| February 17, 2017 | 2.024 |
| February 16, 2017 | 1.956 |
| February 15, 2017 | 2.040 |
| February 14, 2017 | 2.050 |
| February 13, 2017 | 2.103 |
| February 10, 2017 | 1.798 |
| February 09, 2017 | 2.282 |
| February 08, 2017 | 1.987 |
| February 07, 2017 | 2.103 |
| February 06, 2017 | 1.808 |
| February 03, 2017 | 1.788 |
| February 02, 2017 | 1.788 |
| February 01, 2017 | 1.788 |
| January 31, 2017 | 1.756 |
| January 30, 2017 | 1.733 |
| January 27, 2017 | 1.840 |
| January 26, 2017 | 1.788 |
| January 25, 2017 | 1.788 |
| January 24, 2017 | 1.735 |
| January 23, 2017 | 1.893 |
| January 20, 2017 | 1.840 |
| January 19, 2017 | 1.735 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Insmed Inc | -- |
| NeuroMetrix Inc | 0.4519 |
| Intra-Cellular Therapies Inc | 12.21 |
| Rhythm Pharmaceuticals Inc | 13.82 |
| Amylyx Pharmaceuticals Inc | 0.3081 |
Price to Book Value Related Metrics
| Price | 0.1948 |
| Earnings Yield | -2.98% |
| Market Cap | 81.72M |